Freenome
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3300 Marina Blvd, Brisbane, California, ...Phone Number
(650) 446-6630Website
www.freenome.comRevenue
$30.4 MillionStock Symbol
FRNMIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
1
2
3
3
2
About Freenome
Freenome Holdings, Inc. is a biotechnology company headquartered in Brisbane, California, focused on early cancer detection. Founded in 2014, the company develops blood-based cancer screening tests that combine multiomics, artificial intelligence, and machine learning to detect cancer at early stages using a standard blood draw. Its platform analyzes cell-free DNA, RNA, and proteins, with its SimpleScreen portfolio initially targeting colorectal cancer and advanced adenomas. Freenome partners with pharmaceutical companies, health systems, and academic institutions and became publicly traded on Nasdaq under the ticker FRNM following a recent business combination.Explore more
Freenome Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Freenome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Freenome is spiking on competitors!
Earning: See what the market has to say on Freenome recently announced quarterly report
Funding: Get notified immidiatlly once Freenome has new funding data
Product Launch: Get notified when Freenome launches new products
Click to see if Freenome had a recent Job posting/layoffs
Freenome, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Freenome
Check if Freenome has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Freenome
Compare insights from companies similar to Freenome, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Freenome is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Freenome is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Freenome.
Freenome financials insights
Gather financial insights about Freenome, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$7M
2019
Series B
$160M
2020
Series C
$270M
2021
Series D
$300M
2022
Other Financing Round
$290M
2024
Other Financing Round
$254M
2025
Stock/Share Issuance
$75M
Freenome Tech Stack
A closer look at the technologies used by Freenome
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
Freenome News & Media
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening TestFDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer DetectionFreenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints
– Updated test version achieved significant performance improvement in detecting advanced precancerous lesions, including those with high-grade dysplasia – – Modeling projects the improvements would translate to 1,582 additional life-years gained (7.7%), 426 fewer CRC cases (9.5%) and 143...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Freenome
Sign Up For FreeTo access detailed company insights
Freenome Holdings, Inc. is a biotechnology company headquartered in Brisbane, California, focused on early cancer detection. Founded in 2014, the company develops blood-based cancer screening tests that combine multiomics, artificial intelligence, and machine learning to detect cancer at early stages using a standard blood draw. Its platform analyz... Read More
